Benzodiazepines for the long-term treatment of anxiety disorders?

Prashant Tibrewal, Jeffrey C.L. Looi, Stephen Allison, Tarun Bastiampillai

Research output: Contribution to journalLetterpeer-review

9 Citations (Scopus)


In their Seminar, Brenda Penninx and colleagues have strongly cautioned against the long-term use of benzodiazepines for anxiety disorders, commenting that these drugs only act acutely, lead to relapse after discontinuation, and are associated with dependency. Penninx and colleagues propose that benzodiazepines should only be administered as a short-term adjunct and never as monotherapy. We believe that this conclusion is not evidence-based and risks biasing clinicians against an important medication for refractory anxiety disorders.
Original languageEnglish
Pages (from-to)119-120
Number of pages2
JournalThe Lancet
Issue number10295
Publication statusPublished - 10 Jul 2021


  • benzodiazepines
  • anxiety disorders
  • anxiety management
  • Drug dependence
  • short-term usage
  • monotherapy


Dive into the research topics of 'Benzodiazepines for the long-term treatment of anxiety disorders?'. Together they form a unique fingerprint.

Cite this